Pediatric Opioid Endemic by Maynard, Olivia & Watson, Molly
Marshall University 
Marshall Digital Scholar 
Theses, Dissertations and Capstones 
2020 
Pediatric Opioid Endemic 
Olivia Maynard 
Molly Watson 
Follow this and additional works at: https://mds.marshall.edu/etd 
 Part of the Business Administration, Management, and Operations Commons, Health and Medical 
Administration Commons, and the Substance Abuse and Addiction Commons 
Recommended Citation 
Maynard, Olivia and Watson, Molly, "Pediatric Opioid Endemic" (2020). Theses, Dissertations and 
Capstones. 1287. 
https://mds.marshall.edu/etd/1287 
This Research Paper is brought to you for free and open access by Marshall Digital Scholar. It has been accepted 
for inclusion in Theses, Dissertations and Capstones by an authorized administrator of Marshall Digital Scholar. For 
more information, please contact zhangj@marshall.edu, beachgr@marshall.edu. 
Maynard, Urian-Watson   April, 2020   HCA 695- Draft 3 
1 
PEDIATRIC OPIOID ENDEMIC 
ABSTRACT 
Introduction 
As of 2017, 54 out of every 1,000 children born in West Virginia were affected by opioid use. 
NAS Centers provided care to infants who have been diagnosed with, or have been vulnerable to 
develop, NAS. The purpose of this research study reviewed the Pediatric Opioid Endemic 
happening in West Virginia and determined if NAS programs and prenatal opioid maintenance 
therapy would increase access to NAS patients and decrease the cost of treatments. 
Methodology 
The methodology was a literature review. Thirty-nine sources were referenced for this literature 
from 2010-2020. 
Results 
This review examined sources of the Pediatric Opioid Endemic in West Virginia. This review 
focused on NAS programs and how prenatal opioid maintenance therapy can increase access to 
NAS Patients. This decreased the number of infants diagnosed with NAS and decreased the cost 
of treatments for infants and mothers.   
Discussion/Conclusion 
The purpose of this research paper was that NAS Centers and prenatal opioid maintenance 
therapy would help improve the pediatric opioid endemic by decreasing the number of NAS 
patients and decrease the cost of treatments for infants. The review explored research and an 
expert in NAS therapy was conducted. The results from this showed that NAS Centers offering 
therapy to both mother and patients will decrease the amount of infants diagnosed with NAS and 
decrease the cost of treatments.   
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INTRODUCTION 
Neonatal Abstinence Syndrome (NAS) has been described as a postpartum drug withdrawal 
condition that typically transpires among opioid-exposed newborns following birth (Ko, et al, 
2016). Opioids have been defined as prescribed or illegal classes of drugs utilized to decrease 
pain (CDC, 2018). NAS has been associated with central nervous system sensitivity, autonomic 
hyperactivity, and gastrointestinal issues (Ko, et. al, 2016). NAS has been labelled as a short-
term occurrence that ranges in severity where some infants need treatment while others do not 
(NAS, 2017).  
 Endemic has been referred to as a disease or condition amidst specific people within a 
given area (Lexico, 2020). The state with the highest opioid death rate in the nation has been 
West Virginia (Cenziper, Corio, Hooper, Soule, 2019). Every 137.6 per 100 people in West 
Virginia have been prescribed an opioid (Lilly, et al. 2019). In 2018, West Virginia had 51.5 
drug overdose deaths per 100,000 people (Hedegaard, Minino, Warner, 2020). WV has the third 
highest age-adjusted death rate from drug poisoning in the country and the third-highest 
prescribing rate of opioids (Paulozzi, Mack, Hockenberry, 2014). 
As of 2017, 54 out of every 1,000 children born in West Virginia were affected by opioid 
use (Knisely, 2019). More specifically, in Bluefield, West Virginia, nearly 3.5% of newborns 
were diagnosed with drug withdrawal in 2017 (Patrick, 2019). The crisis is not only happening 
across America, but hurting small towns and taking a toll on pregnant women and their babies 
(Patrick, 2019). From 2009 to 2015, the number of Medicaid-covered infants in West Virginia 
that were diagnosed with NAS was documented at 6 million births, which is higher than any 
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other city (Patrick, 2019). The opioid crisis has not only been a healthcare problem, but has 
grown into a social problem resulting in babies being treated for drug withdrawal (Patrick, 2019). 
West Virginia, Tennessee, and Kentucky have had the highest NAS incidence rates with 
1,058 to 4,172 NAS infants per 1,000 births (Wolf, Tong, Sabo, Woolf, Abbinanti, Pecsok, Krist, 
2019). NAS has been found typical among 25% of states with high amounts of rural residents 
(Wolf, et. al, 2019). While West Virginia has also had the highest incidence of NAS in the 
United States (U.S.), 33.4 per 1,000 newborns, the state has also spearheaded strategies to 
improve the issue nationwide (Gottlieb, Davies, Wright, 2018).   
 The public’s focal point has not been on whether the opioid was prescribed by a 
healthcare provider for conditions, including pain management or treatment for Opioid Use 
Disorder (OUD), or the mother has abused medications and illegal opioids (NAS, 2017). In 
2018, Healthy Connections was developed to supply family services, promoted policy change 
and increased treatment options, researched and applied procedures, and provided substance use 
disorder education (Gottlieb, et. al, 2018). 
 NAS Centers (NASC) have been described as organizations that deliver care to infants 
who have been diagnosed with, or have been vulnerable to develop, NAS (WVDHHR, 2019). 
The WVDHHR has received authorization from the U.S. Centers for Medicare and Medicaid 
Services (CMS) to offer NAS treatment services, including complete assessments, 
Pharmaceutical Withdrawal Treatment, slow presentation of sensory stimuli, and observing 
withdrawal objective assessments, and West Virginia was the first state to receive approval 
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(WVDHHR, 2018). Due to the opioid epidemic, there have been more drug-addicted babies in 
West Virginia compared to any other state and opening up these centers in the state has 
established a mechanism that helps fight the opioid epidemic (Hodousek, 2018). The West 
Virginia NAC licensure rule has required a NASC to have at least two licensed nurses present 
during each period of work (WVDHHR, 2019). NAS centers have offered pharmacological and 
non-pharmacological techniques to intervene during the withdrawal process (WVDHHR, 2018).   
The Neonatal Therapeutic Unit (NTU) at Hoops Family Children’s Hospital in 
Huntington, West Virginia, opened its doors in 2012 with the purpose to care for babies 
experiencing NAS (Murray, 2017). Within the first five years, the unit exceeded the 12-bed 
capacity and had to allow change to meet the needs of patients and parents (Murray, 2017). The 
NTU has been used when babies do not need the services offered in the Neonatal Intensive Care 
Unit (NICU), but have found comfort in the NTU staff’s support (Hoops Children’s Hospital, 
2020). The NTU has also involved family members in the babies’ care, creating practices that 
can be utilized after the hospital stay (Hoops Children’s Hospital, 2020).  
In 2014, Lily’s Place was the first NAS center to open in the U.S. in Huntington, West 
Virginia, and has received national attention (Null, 2018).  Lily’s Place has delivered care to 
West Virginia babies experiencing the withdrawal process and families learning the 
fundamentals of how to care for a NAS infant (Null, 2018). Cabell Huntington Hospital in West 
Virginia had initiated Lily’s Place and Cabell Huntington Hospital’s NTU (Powell, 2019). The 
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United States’ first interim care nursery, Pediatric Interim Care Center (PICC), located in Kent, 
Washington, was the motivation for the establishment (Powell, 2019).  
Lily’s Place has been the first in the state to receive the U.S. Centers for Medicare and 
Medicaid Services’ approval for reimbursement for NAS treatments (Snoderly, 2018). The 
facility has received funding from the state since opening its doors, covering approximately 60% 
of the center’s costs (Snoderly, 2018). In 2018, Lily’s Place received a $500,000 grant from 
Pfizer to continue offering advanced neonatal care and support for mothers. The services from 
Cabell Huntington Hospital’s MOMs program have been incorporated into Lily’s Place plan-of-
care to ensure comprehensive services are available (The Herald-Dispatch, 2018). Once an infant 
has become a Lily’s Place patient, Child Protective Services (CPS) has made certain that family 
members, including mothers, have been taking the necessary steps to become clean (Davis, 
2016a).  
Lily’s Place has influenced federal bills including the NAS Healthy Babies Act (Davis, 
2016b). The act has mandated the Government Accountability Office (GAO) to disclose 
information on NAS (CRS, 2016).  The NAS Healthy Babies Act would have also given 
nationwide facilities the opportunity to replicate Lily’s Place (Davis, 2016b). The bill was 
introduced on April 18, 2018, to U.S. Congress, but had not been enacted due to dying in a 
previous Congress (GovTrack, 2020).  
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The purpose of this research study reviewed the Pediatric Opioid Endemic happening in 
West Virginia and determined if NAS programs and prenatal opioid maintenance therapy would 
increase access to NAS patients and decrease the cost of treatments. 
 
METHODOLOGY 
The methodology for this study was literature research and review of case studies and a semi-
structured interview. The primary hypothesis for this research paper was that NAS Centers and 
prenatal opioid maintenance therapy would help improve the pediatric opioid endemic by 
decreasing morbidity in NAS patients and decrease the cost of treatments for infants. 
 
Search Strategy 
      The review utilized in this study about Pediatric Opioid Endemic in West Virginia was 
composed of primary and secondary data. The conceptual framework, illustrated by Figure 1, for 
this review was adapted from the steps and research used by Morgan and Wang (2019). The 
research method was an adoption of the framework showing the linkages between early exposure 
to opioids such as maternal prescribed use, a child's subsequent risk for disability, and results of 
receiving special education services. Throughout the process assessment, the use of opioid 
maintenance and education services among the fetal and infant stages and how they affected the 
early childhood stages. The framework explored the exposure to opioids in utero and linked them 
to the postnatal effects through environmental contexts. Maternal opioid use has been said to 
result in NAS, as well as cognitive, physical, and behavioral impairments. See Figure 1.  
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The literature was conducted in three stages: (1) developing a search strategy and 
gathering data; (2) determining and analyzing the relevant literature; (3) allotting literature to 
appropriate categories. 
 
Step 1: Literature Identification and Collection 
          When implementing the search, the following keywords were employed: “pediatric 
opioid endemic” AND “neonatal abstinence syndrome” OR “NAS” AND “prenatal opioid 
maintenance” OR “opioid therapy”. The following electronic databases were utilized to gather 
literature: Medline, Access Pharmacy, PubMed and Google Scholar. The Center for Disease 
Control and Prevention, National Academy of Sciences, National Institute of Health, and West 
Virginia Department of Health and Human Resources were reliable websites that were also 
minded in the review.  PRISMA was used as an overview for the literature evaluation for 
reporting systematic reviews and meta-analyses..The search identified 540 relevant citations and 
articles were excluded (N= 506) if they did not meet inclusion principles. Articles were included 
(N= 34) if they described the pediatric opioid endemic and NAS centers: articles from other 
sources (N=17) were also minded in this search. These 34 references were subject to full-text 
review, and these 34 citations were included in the data abstraction and analysis. Only 39 
references were used in the results section. (See Figure 2). 
A semi-structured interview with an expert was conducted regarding the pediatric opioid 
endemic happening in West Virginia. This expert was an Executive Director at Lily’s Place in 
Huntington, West Virginia, and was referred to as an expert in NAS. This individual was chosen 
for the semi-structured interview due to her high amount of experience in recovery 
administration. This semi-structured interview was IRB approved and took place via phone.  
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Step 2: Establishment of Inclusion Criteria and Literature Analysis 
The Pediatric Opioid Endemic has become important because of its impact on West 
Virginia. Therefore ,the literature analyzed focused on the following key areas: Opioid Endemic 
in West Virginia, Neonatal Abstinence Syndrome (NAS), Specific Drug Trends, and NAS 
therapy.  The articles written in the English were published between 2010 and 2020. Thirty-nine  
were utilized for this research study. This literature search was conducted by OM and MW and 
validated by AC, who acted as the second reader and double checked to ensure that references 
met the inclusion criteria. 
 
Step 3: Literature Categorization 
The following subheadings were included in the research: Pediatric Opioid Endemic in 
West Virginia, NAS and Drug Specific Trends, NAS Centers and NAS Treatment, Prenatal 
Opioid Maintenance, and Maintenance Programs.  
 
RESULTS 
Pediatric Opioid Endemic in West Virginia 
An umbilical cord tissue study was completed in eight West Virginia hospitals, where infants 
were tested on the exposure to licit/illicit drugs and alcohol (Lilly, et al. 2019). The study 
showed that 20% of the infants had been exposed (Lilly, et al. 2019). In 2010, Charleston Area 
Medical Center (CAMC) in West Virginia stated that 1 and 3 women tested positive for opioid 
abuse (Harold, 2011). The study included 706 pregnant mothers between July 2010 and July 
2011 were tested for drug use and 74% tested positive for marijuana, 20% tested positive for 
opioids, 12% tested positive for Benzodiazepines, and 6% tested for Methadone (Harold, 2011).  
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Another study completed by Stitely, et al. (2010) tested 759 pregnant women in West Virginia 
for drug and alcohol abuse and 146 or 19.2% tested positive. 
NAS and Drug Specific Trends 
The opioid epidemic has had consequences that have affected pregnant women and NAS 
has been diagnosed in 55%-94% of newborns (Nair, Soraisham, and Akierman, 2012).   This has 
caused health complications during pregnancy for the infant and caused by the use of Heroin, 
Codeine, Oxycodone, methadone, and Buprenorphine (Medline Plus, 2017). Hospital charges for 
NAS have reached $1.5 billion in 2012, with 81% of the cost being charged to state Medicaid 
programs (Patrick, Davis, Lehman, and Cooper, 2015). Between 2004 and 2014, the amount of 
NAS cases in West Virginia increased from 1.5 cases per 1,000 births to 8.0 cases per 1,000 
hospital births (NIH, 2019). This has been the same as an infant being born with symptoms of 
NAS every fifteen minutes (NIH, 2019). Hospital costs for NAS have increased from $91 million 
to $563 million due to the increase in the number of cases from 2004- 2014 and an increase from 
1.5- 8.0 for NAS incident rates and 150 to 563 million dollar cost inflation.  
138,224 out of 55,781965 hospitalizations in pregnant women were due to the opioid 
crisis (Krans, Cochran, and Bogen, 2015). More than 35% of the women tested positive for 
marijuana, cocaine, benzodiazepines, and 77%-95% had smoked tobacco (Krans, et al, 2015). 
A study completed by Stabler, et al. (2018), examined NAS and drug specific trends in 
West Virginia by examining 119,605 live births in West Virginia hospitals. It was found that 
1,974 of the births were NAS diagnoses and the number of cases diagnosed at birth were 98.4% 
of the total cases (Stabler, et al. 2018). The findings from the study showed that NAS rates have 
continued to rise in West Virginia (Stabler, et al. 2018).  Within the years of 2007 to 2013, the 
rate of newborns diagnosed with NAS in West Virginia increased from 1.89 to 8.09 for narcotics, 
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the diagnosis of hallucinogen exposure did not change over time, and the diagnosis of cocaine 
exposure decreased from 1.77 to 0.74 per 1,000 live births (Stabler, et al. 2018). 
 
NAS Centers and NAS Treatment 
NAS centers were created to help treat babies who have been born addicted to drugs, 
allowing Lily's Place and the Neonatal Therapeutic Unit (NTU) at Hoops Family Children’s 
Hospital to be recognized and treat infants (Hodousek, 2018). Each year, the state Medicaid 
program has covered more than $1 billion to care for infants with NAS (Normile and Hanlon, 
2018). In February 2018, the Centers for Medicare and Medicaid Services (CMS) approved a 
new financing approach to be more cost efficient for state Medicaid programs covering the cost 
of NAS treatments (Normile and Hanlon, 2018). The average hospital stay for an infant with 
NAS has been 17 days and has cost nearly $93,000 and non-hospital treatments for infants with 
less severe cases of NAS have ranged from $600-$2,600 per treatment (Normile and Hanlon, 
2018). 
 
Prenatal Opioid Maintenance 
Opioid use during pregnancy has increased the risk of NAS in linked to other 
complications throughout the pregnancy and has resulted in the infant needing treatment such as 
buprenorphine (Nguyen, et al. 2018). Although NAS has been a serious condition, the mothers of 
the infants should receive treatment of buprenorphine during and after the pregnancy to quit the 
use of drugs. Methadone and buprenorphine have been used to help treat the baby of opioid use 
during pregnancy (Nguyen, et al. 2018). Buprenorphine has been a formula used to help limit 
fetal exposure due to fetal withdrawal, potential mix of hormones, and behavioral effects 
(Nguyen, et al. 2018). Studies have shown that individuals treated with methadone and 
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buprenorphine during the pregnancy have infants who are less likely to be diagnosed with NAS, 
had a lower peak NAS during treatment, and improved delivery (Wiegand, et al, 2015). The 
study included 62 mothers, 31 of those were treated with methadone and the other 31 were 
treated with buprenorphine and naloxone. The methadone group had a Neonatal Abstinence 
Syndrome (NAS) diagnosis of 51.6% compared to the buprenorphine and naloxone group who 
had a NAS diagnosis of 25.1% (Wiegand, et al, 2015).  
 
Maintenance Programs 
Drug Free Moms and Babies Program (DFMB) has been a program in West Virginia that 
has been offered to mothers and children that suffer from substance abuse (Greenbrier Valley 
Medical Center, 2020). The goal of the program has been to have healthier outcomes for the 
mother and baby, and this has been done by providing prevention, early intervention, education, 
addiction treatment, and recovery support services (Greenbrier Valley Medical Center, 2020).  
Medication-Assisted Treatment (MAT) has been the standard care for those with opioid use 
disorder and has been the safest, most effective treatment (Greenbrier Valley Medical Center, 
2020).  
DISCUSSION  
The purpose of this research study reviewed the Pediatric Opioid Endemic happening in West 
Virginia and determined if NAS programs and prenatal opioid maintenance therapy would 
increase access to NAS patients and decrease the cost of treatments. The primary hypothesis for 
this research paper was that NAS Centers and prenatal opioid maintenance therapy would help 
improve the pediatric opioid endemic by decreasing the number of NAS patients and decrease 
the cost of treatments for infants. Results from the literature review have shown that West 
Virginia has continued to have an increased number of NAS births and have addressed the issue 
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by establishing NAS centers such as Lily’s Place, a Neonatal Therapeutic Unit (NTU), and the 
Drug Free Moms and Babies Program that have offered NAS services during and after 
pregnancies to mothers and babies.  
The opioid crisis has developed from a healthcare issue to a social issue nationwide. NAS 
has been diagnosed in 55%-94% of newborns. Opioid use during pregnancy has caused 
pregnancy issues and have resulted in NAS treatment for the infant. Heroin, Codeine, 
Oxycodone, Methadone, and Buprenorphine have produced health difficulties for NAS babies. 
By 2012, NAS related charges in hospitals totaled $1.5 billion and 81% was charged to state 
Medicaid programs. In West Virginia, every 137.6 per 100 people have been prescribed an 
opioid. A 2018 study focused on 119,605 live births in WV hospitals and discovered that 1,974 
of the births were NAS diagnoses. 
West Virginia has had the highest number of drug-addicted babies than any other state. 
Several movements have taken place in West Virginia to fight the pediatric opioid endemic. 
NAS Centers have offered pharmacological and nonpharmacological treatments to infants. Lily’s 
Place opened in 2014 and was the first NAS center to open within the United States. Babies who 
have gone through the withdrawal process have been treated at Lily’s Place while parents have 
been taught the basics to care for an NAS infant.  
Lily’s Place Executive Director, Rebecca Crowder, was interviewed via phone 
conference. While Lily’s Place has been licensed to allow up to 16 babies at a time, the facility 
has preferred no more than 14 babies to leave space for a set of twins. The average length of stay 
for a Lily’s Place patient has been 30 days. Crowder stated that Lily’s Place has offered services 
including medication and therapeutic handling to babies going through the withdrawal process. 
Mothers have been provided peer support specialists and rooming-in, which has added to the 
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recovery program already in place. Fathers and families have also been involved with treatment 
plans including CPR, first aid, follow-up clinics, counselors, and social work. Crowder stated 
that since opening in 2014, the number of neonatal patients has steadied out because the choice 
of drugs has shifted and obvious, exposure symptoms have been different.  
In 2012, the NTU opened in Huntington, West Virginia, at the Hoops Family Children’s 
Hospital. When infants have not benefited from the services offered in the hospital NICU, the 
NTU has been utilized to care for NAS babies. In 2012, hospital charges for NAS reached $1.5 
billion. Prevention and treatment for NAS should have begun before, during, and after 
pregnancy. The Drug Free Moms and Babies Program (DFMB) was established in West Virginia 
with an ultimate goal of providing prevention, intervention, education and treatment to mothers 
and infants.  
 
Study Limitations  
This study was limited due to the number of databases used for the secondary search, 
restraints in the literature search strategy, and bias of the researchers. The study was focused on 
NAS prevention, intervention, and treatment in West Virginia and detailed research for other 
states was not included.  
 
Practical Implications  
NAS Centers have been established in West Virginia and have provided care to NAS 
babies and mothers. West Virginia NAS Centers have become a model for other states that have 
also battled the pediatric opioid endemic. Treatment models from Lily’s Place and other NAS 
Centers within West Virginia have created a way for health care providers nationwide to care for 
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NAS infants. The continued use of such models and prenatal opioid maintenance therapy will 
decrease the NAS morbidity and cost of treatments.  
 
CONCLUSION 
The purpose of this research paper was that NAS Centers and prenatal opioid maintenance 
therapy would help improve the pediatric opioid endemic by decreasing the number of NAS 
patients and decrease the cost of treatments for infants. The review explored research and an 
expert in NAS therapy was conducted. The results from this showed that NAS Centers offering 
therapy to both mothers and patients, will decrease the amount of infants diagnosed with NAS 
and decrease the cost of treatments.  
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Figure 2. PRISMA- Overview of Literature Evaluation. 
Records identified from 
the search for title and 
abstract review 
N=540 





































This research paper will include a semi-structured interview with Lily’s Place Executive 
Director, Rebecca Crowder. 
1.     What treatments are available at Lily's Place for babies going through the 
withdrawal process? 
2.     How many patients can be enrolled at once? Why? Why not? 
3.     What specific treatments and/or programs are offered to mothers? Why? 
4.     Compared to when Lily's Place opened in 2014, how much of an increase have you 
seen in neonatal patients? Why? 
5.     How does Lily's Place adapt to the increasing needs of patients? Why? 
6.     How has Huntington's pediatric opioid endemic and Lily's Place helped create a 
replication plan? Why? 
7.     What is the average length of stay for a Lily's Place patient? Why? 
8.     As executive director, what techniques do you utilize to lead your team members 
and fulfill the Lily's Place mission? Why? 
9.     What are the requirements of the patient's guardian to receive guardianship? Why? 
10.  Are families involved in Lily’s place after treatment? Why? Why not? 
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11.  If a patient’s parent does not want to keep guardianship, does Lily’s place facilitate 
adoptions? Why? Why not? 
 
 
 
 
